Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East

References

• KellyBBNarulaJFusterVRecognizing global burden of cardiovascular disease and related chronic diseasesMt Sinai J Med201279663264023239202
   PubMedGoogle Scholar
• Alsheikh-AliAAOmarMIRaalFJCardiovascular risk factor burden in Africa and the Middle East: the Africa Middle East Cardiovascular Epidemiological (ACE) studyPLoS One201498e10283025090638
   PubMed Web of Science ®Google Scholar
• YangZJLiuJGeJPChenLZhaoZGYangWYChina National Diabetes and Metabolic Disorders Study GroupPrevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China National Diabetes and Metabolic Disorders StudyEur Heart J201233221322021719451
   PubMed Web of Science ®Google Scholar
• GaoFZhouYJHuDYContemporary management and attainment of cholesterol targets for patients with dyslipidemia in ChinaPLoS One201384e4768123593110
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal Health Observatory (GHO) data Available from: http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/Accessed March 14, 2018
   Google Scholar
• LawMRWaldNJThompsonSGBy how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ199430869253673728043072
   PubMed Web of Science ®Google Scholar
• HendraniADAdesiyunTQuispeRDyslipidemia management in primary prevention of cardiovascular disease: current guidelines and strategiesWorld J Cardiol20168220121026981215
   PubMedGoogle Scholar
• Al SayedNAl WailiKAlawadiFConsensus clinical recommendations for the management of plasma lipid disorders in the Middle EastInt J Cardiol201622526828327741487
   PubMed Web of Science ®Google Scholar
• Al RasadiKAlmahmeedWAlHabibKFDyslipidaemia in the Middle East: current status and a call for actionAtherosclerosis201625218218727522462
   PubMed Web of Science ®Google Scholar
• GuDGuptaAMuntnerPPrevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia)Circulation2005112565866516043645
   PubMed Web of Science ®Google Scholar
• CaiLZhangLLiuALiSWangPPrevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, ChinaJ Atheroscler Thromb201219215916822041495
   PubMed Web of Science ®Google Scholar
• LuoJYMaYTYuZXPrevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk surveyLipids Health Dis201413424393232
   PubMed Web of Science ®Google Scholar
• GePDongCRenXThe high prevalence of low HDL-cholesterol levels and dyslipidemia in rural populations in Northwestern ChinaPLoS One20151012e014410426640891
   PubMed Web of Science ®Google Scholar
• SoebardiSPurnamasariDOemardiMSoewondoPWaspadjiSSoegondoSDyslipidemia in newly diagnosed diabetes mellitus: the Jakarta primary non-communicable disease risk factors surveillance 2006Acta Med Indones200941418619020124614
   PubMedGoogle Scholar
• HatmaRDLipid profiles among diverse ethnic groups in IndonesiaActa Med Indones201143141121339539
   PubMedGoogle Scholar
• Institute for Public Health (IPH) 2015National Health and Morbidity Survey 2015 (NHMS 2015). Vol. II:n-Communicable Diseases, Risk Factors & Other Health Problems2015 Available from: http://iku.moh.gov.my/index.php/research-eng/list-of-research-eng/iku-eng/nhms-eng/nhms-2015
   Google Scholar
• Food and Nutrition Research Institute8th National Nutrition Survey (Philippines)2013 Available from: http://122.53.86.125/NNS/8thNNS.pdfAccessed March 14, 2018
   Google Scholar
• PanWHWuHJYehCJDiet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993–1996 and 2005–2008Asia Pac J Clin Nutr201120223825021669593
   PubMed Web of Science ®Google Scholar
• AekplakornWTaneepanichskulSKessomboonPPrevalence of dyslipidemia and management in the Thai population, National Health Examination Survey IV, 2009J Lipids2014201424958424800083
   PubMedGoogle Scholar
• BasulaimanMEl BcheraouiCTuffahaMHypercholesterolemia and its associated risk factors – Kingdom of Saudi Arabia, 2013Ann Epidemiol2014241180180825281531
   PubMed Web of Science ®Google Scholar
• HajatCHarrisonOAl SiksekZWeqaya: a population-wide cardiovascular screening program in Abu Dhabi, United Arab EmiratesAm J Public Health2012102590991421940918
   PubMed Web of Science ®Google Scholar
• IqbalSPDodaniSQureshiRRisk factors and behaviours for coronary artery disease (CAD) among ambulatory PakistanisJ Pak Med Assoc200454526126615270186
   PubMedGoogle Scholar
• Al-NozhaMMArafahMRAl-MaatouqMAHyperlipidemia in Saudi ArabiaSaudi Med J200829228228718246242
   PubMed Web of Science ®Google Scholar
• BasitASheraASPrevalence of metabolic syndrome in PakistanMetab Syndr Relat Disord20086317117518699720
   PubMedGoogle Scholar
• Al-DaghriNMAl-AttasOSAlokailMSAlkharfyKMSabicoSLChrousosGPDecreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult ArabsPLoS One201058e1215920730053
   PubMed Web of Science ®Google Scholar
• SyRGMoralesDDDansALPrevalence of atherosclerosis-related risk factors and diseases in the PhilippinesJ Epidemiol201222544044722813647
   PubMed Web of Science ®Google Scholar
• RutherfordJNMcDadeTWFeranilABAdairLSKuzawaCWHigh prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMIAsia Pac J Clin Nutr2010191576720199988
   PubMed Web of Science ®Google Scholar
• RosensonRSBrewerHBJrBarterPJHDL and atherosclerotic cardiovascular disease: genetic insights into complex biologyNat Rev Cardiol201815191928795686
   PubMed Web of Science ®Google Scholar
• JainAPuriRNairDRSouth Asians: why are they at a higher risk for cardiovascular disease?Curr Opin Cardiol201732443043628505046
   PubMed Web of Science ®Google Scholar
• MotlaghBO’DonnellMYusufSPrevalence of cardiovascular risk factors in the Middle East: a systematic reviewEur J Cardiovasc Prev Rehabil200916326828019398913
   PubMedGoogle Scholar
• AlmahmeedWArnaoutMSChettaouiRCoronary artery disease in Africa and the Middle EastTher Clin Risk Manag20128657222368447
   PubMed Web of Science ®Google Scholar
• NguyenHNFujiyoshiAAbbottRDMiuraKEpidemiology of cardiovascular risk factors in Asian countriesCirc J201377122851285924240435
   PubMed Web of Science ®Google Scholar
• MahmoodDJahanKHabibullahKPrimary prevention with statins in cardiovascular diseases: a Saudi Arabian perspectiveJ Saudi Heart Assoc201527317919126136632
   PubMed Web of Science ®Google Scholar
• Joint Committee for Revision of Chinese guidelines for prevention and treatment of dyslipidemia in adultsChinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (2016 edition)Chin Circulation J201610937953 Chinese
   Google Scholar
• Perkumpulan Endokrinologi IndonesiaPanduan Pengelolaan Dislip-idemia di Indonesia. [Guidelines for management of dyslipidemia in Indonesia]PB PERKENI2015978-979-19388-5-3Indonesian
   Google Scholar
• Malaysian Ministry of HealthManagement of Dyslipidaemia Guidelines 2017 (5th edition) Available from: http://www.moh.gov.my/pener-bitan/CPG2017/CPG%20Management%20of%20Dyslipidaemia%202017%20(5th%20Edition).pdfAccessed March 14, 2018
   Google Scholar
• GuerreroAEGonzalez-SantosLECaole-AngIV2015 Clinical practice guidelines for the management of dyslipidemia in the Philip-pines – executive summary: dyslipidemia guidelines 2015ASEAN Heart J2016241106111
   Google Scholar
• LiYHUengKCJengJSWriting Group of 2017 Taiwan Lipid Guidelines for High Risk Patients2017 Taiwan lipid guidelines for high risk patientsJ Formos Med Assoc2017116421724828242176
   PubMed Web of Science ®Google Scholar
• The Royal College of Physicians of Thailand2016 RCPT Clinical Practice Guideline on Pharmacologic Therapy of Dyslipidemia for Atherosclerotic Cardiovascular Disease Prevention Available from: http://www.thaiheart.org/download/2016-RCPT-Dyslipidemia-Guideline.htmlAccessed March 14, 2018
   Google Scholar
• StoneNJRobinsonJGLichtensteinAHAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 Suppl 2S1S4524222016
   PubMed Web of Science ®Google Scholar
• Giner-GalvañVEsteban-GinerMJPallarés-CarrataláVOverview of guidelines for the management of dyslipidemia: EU perspectivesVasc Health Risk Manag201612357369 eCollection 201627660458
   PubMed Web of Science ®Google Scholar
• European Association for Cardiovascular Prevention & RehabilitationReinerZCatapanoALDe BackerGESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 CommitteesESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
   PubMedGoogle Scholar
• RabarSHarkerMO’FlynnNWierzbickiASGuideline Development GroupLipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidanceBMJ2014349g435625035388
   PubMed Web of Science ®Google Scholar
• CatapanoALGrahamIDe BackerG2016 ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)Atherosclerosis201625328134427594540
   PubMed Web of Science ®Google Scholar
• Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel membersAn International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia––full reportJ Clin Lipidol201481296024528685
   PubMed Web of Science ®Google Scholar
• Thai Atherosclerosis SocietyGuidelines for the Primary Prevention of Atherosclerosis Available from: http://www.thaiathero.org/download/guildline_Thai_atherosclerosis_Update_16_07_50.pdfAccessed May 15, 2017
   Google Scholar
• AhnEShinDWYangHKTreatment gap in the National Health-Screening Program in Korea: claim-based follow-up of statin use for sustained hypercholesterolemiaJ Korean Med Sci20153091266127226339166
   PubMed Web of Science ®Google Scholar
• RobsonJHippisley-CoxJCouplandCQRisk superior in diverse South Asian groupsInt J Clin Pract201266772222698426
   PubMed Web of Science ®Google Scholar
• KalraSHealth risk calculators for PakistanJ Pak Med Assoc201666121669167028179709
   PubMed Web of Science ®Google Scholar
• LiauSYMohamed IzhamMIHassaliMAShafieAAA literature review of the cardiovascular risk-assessment tools: applicability among Asian populationHeart Asia201021151827325935
   PubMedGoogle Scholar
• HussainSMOldenburgBWangYZoungasSTonkinAMAssessment of cardiovascular disease risk in South Asian populationsInt J Vasc Med2013201378680124163770
   PubMedGoogle Scholar
• SelvarajahSKaurGHaniffJComparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian populationInt J Cardiol2014176121121825070380
   PubMed Web of Science ®Google Scholar
• ChiaYCGraySYChingSMLimHMChinnaKValidation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort studyBMJ Open201555e007324
   Web of Science ®Google Scholar
• Asia Pacific Cohort Studies CollaborationBarziFPatelAGuDCardiovascular risk prediction tools for populations in AsiaJ Epidemiol Community Health200761211512117234869
   PubMed Web of Science ®Google Scholar
• LiaoJKSafety and efficacy of statins in AsiansAm J Cardiol200799341041417261409
   PubMed Web of Science ®Google Scholar
• GuptaMMartineauPTranTACTFAST investigatorsLow-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) studyJ Clin Pharmacol201252685085821610204
   PubMed Web of Science ®Google Scholar
• ThongtangNSitthananunCSriussadapornSNitiyanantWEfficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patientsJ Diabetes Metab Disord201716628289653
   PubMed Web of Science ®Google Scholar
• LeeBDumrongkitchaipornKSriussadapornSThongtangNStatin intensity regimens in Thai type 2 diabetic patients who achieved LDL-C targetsJ Med Assoc Thai20171005603611
   Google Scholar
• FengQWeiWQChungCPThe effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapyPharmacogenomics J201717220420826902539
   PubMed Web of Science ®Google Scholar
• ChanJCKongAPBaoWFayyadRLaskeyRSafety of atorvastatin in Asian patients within clinical trialsCardiovasc Ther201634643144027520479
   PubMed Web of Science ®Google Scholar
• LiDQKimRBMcArthurEStatin safety in Chinese: a population-based study of older adultsPLoS One2016113e015099026954681
   PubMed Web of Science ®Google Scholar
• LauTWTanKEKChooJCJNgTGTavintharanSChanJCNRegional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunctionJ Diabetes201810320021228960806
   PubMed Web of Science ®Google Scholar